Dr Jeffrey Goh 956 Gympie Road, Chermside, Queensland 4032

Welcome to Dr Jeffrey Goh's institution, located at Chermside, Gympie Road, 956. Dr Goh is a highly dedicated and experienced medical oncologist who is committed to providing the best possible outcomes for his patients. With a combination of expertise in research and clinical trials, as well as a compassionate approach to care, he ensures that his patients receive the support they need throughout their cancer journey.

Dr Jeffrey Goh is an Adjunct Professor at Queensland University of Technology (QUT) and consults and treats patients at Icon Cancer Centre Chermside, Icon Cancer Centre Greenslopes, and Icon Cancer Centre Wesley. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Monash University in 1996 and then moved to Adelaide for his residency. In 2002, he began his specialist career at Greenslopes Private Hospital as a haematology and oncology registrar. He furthered his training at Princess Alexandra Hospital and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 2007.

Dr Goh's dedication to the field of oncology is evident through his involvement in numerous clinical trials. He has acted as a principal investigator in phase I/Ib, II, and III trials in gynaecological oncology, urological malignancy, and early phase drug trials. He is also a co-investigator in several multi-centre clinical trials in oncology. Dr Goh is a member of esteemed cancer trial groups such as the Australian and New Zealand Urogenital & Prostate Cancer Trials Group (ANZUP), American Society of Clinical Oncology (ASCO), International Gynecologic Cancer Society (IGCS), and European Society of Medical Oncology (ESMO).

In addition to his clinical work, Dr Goh is actively involved in research and education. He is a co-supervisor of PhD candidates at the University of Queensland and has served as a senior lecturer. He also mentors advanced trainee registrars in medical oncology at Royal Brisbane & Women's Hospital (RBWH). Dr Goh is a member of Icon's Research Committee and Medical Advisory Committee (MAC), further emphasizing his commitment to advancing the field of oncology.

Dr Goh's clinical experience encompasses a wide range of solid tumour malignancies, with a particular interest in gynaecological cancer, genitourinary cancer, and colorectal cancers. He also specializes in phase I/Ib clinical trials. His expertise and dedication to his patients make him a trusted choice for those seeking comprehensive and compassionate oncology care.

If you or a loved one is in need of expert oncology care, we invite you to schedule an appointment with Dr Jeffrey Goh at his institution. With his extensive experience, commitment to research, and empathetic approach to care, you can trust that you will receive the highest level of treatment and support throughout your cancer journey.

Notable clinical trials Dr Goh is involved in:

- A Phase 3, Randomized, Open-Label, Controlled Study of Cabozantinib (XL184) in Combination with Atezolizumab vs Second Novel Hormonal Therapy (NHT) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

- A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

- Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases.